Hey Daniel, @Mason14,
Have either of you come across this specific m6a x cardiovascular failure study?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263194/
Mason, I know you’ve worked through and posted a lot on the contrary primary mechanism of FTO inhib x chemo cardio toxic and the secondary cardioprotective mechanism of bisantrene (prefacing M1M), so this article’s commentary on how increased FTO/changes in other m6a agents helps cardiac health markers (i.e improved Ca2+ homeostasis) might be of interest/relevance.
Hey Daniel, @Mason14,Have either of you come across this...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
